APA (7th ed.) Citation

Holyoake, T. L., Alcorn, M. J., Richmond, L., Farrell, E., Pearson, C., Green, R., . . . Franklin, I. M. (1997). CD34 positive PBPC expanded ex vivo may not provide durable engraftment following myeloablative chemoradiotherapy regimens. Bone Marrow Transplantation, 19(11), 1095. https://doi.org/10.1038/sj.bmt.1700799

Chicago Style (17th ed.) Citation

Holyoake, T L., et al. "CD34 Positive PBPC Expanded Ex Vivo May Not Provide Durable Engraftment Following Myeloablative Chemoradiotherapy Regimens." Bone Marrow Transplantation 19, no. 11 (1997): 1095. https://doi.org/10.1038/sj.bmt.1700799.

MLA (9th ed.) Citation

Holyoake, T L., et al. "CD34 Positive PBPC Expanded Ex Vivo May Not Provide Durable Engraftment Following Myeloablative Chemoradiotherapy Regimens." Bone Marrow Transplantation, vol. 19, no. 11, 1997, p. 1095, https://doi.org/10.1038/sj.bmt.1700799.